Benitec Biopharma Inc. (BNTC)
NASDAQ·Healthcare·Biotechnology
$12.19
-0.29%
Mkt Cap $298.17M
Analyst Ratings
No recent rating data.
Price Target (10 analysts)
$20.50
Range $16.00 – $25.00
Implied Upside
+68.2%
Consensus $20.50 vs current $12.19
NASDAQ·Healthcare·Biotechnology
$12.19
-0.29%
Mkt Cap $298.17M
No recent rating data.
Price Target (10 analysts)
$20.50
Range $16.00 – $25.00
+68.2%
Consensus $20.50 vs current $12.19